drugset
drugset / Trial / NCT04753710

Efficacy, Safety and Tolerability Study of Chloroprocaine 3% Gel Eye Drops in Healthy Volunteers

NCT04753710 ↗

Phase 2/3 Completed 96 enrolled Sintetica SA
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The study assess efficacy, safety and tolerability of Chloroprocaine 3% ophthalmic gel in healthy volunteers.

Timeline

Start
2020-06-29
Primary completion
2020-11-06
Completion
2020-12-09

Drugs

EvaluationDrugModalityDoseRoute
Subject Chloroprocaine Other / unclassified 3 % Topical

Indications

No indication recorded.